BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17512417)

  • 1. Use of device diagnostics in the outpatient management of heart failure.
    Germany R; Murray C
    Am J Cardiol; 2007 May; 99(10A):11G-6G. PubMed ID: 17512417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic.
    Small RS
    Am J Cardiol; 2007 May; 99(10A):17G-22G. PubMed ID: 17512418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fundamentals of intrathoracic impedance monitoring in heart failure.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of device diagnostics as an educational tool to improve patient adherence.
    Rathman L
    Am J Cardiol; 2007 May; 99(10A):29G-33G. PubMed ID: 17512420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
    Andriulli J
    Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaboration among general cardiologists, heart failure specialists, and electrophysiologists: what are the barriers?
    Tang WH
    Am J Cardiol; 2007 May; 99(10A):41G-4G. PubMed ID: 17512423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
    Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
    Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key lessons from cases worldwide.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):34G-40G. PubMed ID: 17512422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
    van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
    Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using cardiac resynchronization therapy diagnostics for monitoring heart failure patients.
    Adamson PB
    Heart Fail Clin; 2009 Apr; 5(2):249-60. PubMed ID: 19249693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring intrathoracic impedance in heart failure patients: implications for inpatient use.
    Calabrese MS; Thompson EJ
    Dimens Crit Care Nurs; 2010; 29(5):203-10. PubMed ID: 20703125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches to monitoring heart failure before symptoms appear.
    Abraham WT
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S33-41. PubMed ID: 16955058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
    Vollmann D; Nägele H; Schauerte P; Wiegand U; Butter C; Zanotto G; Quesada A; Guthmann A; Hill MR; Lamp B;
    Eur Heart J; 2007 Aug; 28(15):1835-40. PubMed ID: 17309902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating monitoring into the infrastructure and workflow of routine practice: OptiVol.
    Small R
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S47-55. PubMed ID: 16955060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring and implantable hemodynamic devices for advanced heart failure monitoring in the ambulatory setting and the evolving role of cardiac resynchronization therapy.
    Smith SA; Abraham WT
    Congest Heart Fail; 2011; 17(5):220-6. PubMed ID: 21906246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
    Yamokoski LM; Haas GJ; Gans B; Abraham WT
    Expert Rev Med Devices; 2007 Nov; 4(6):775-80. PubMed ID: 18035943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic monitoring strategies in heart failure management.
    Piccini JP; Hranitzky P
    Am Heart J; 2007 Apr; 153(4 Suppl):12-7. PubMed ID: 17394898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transthoracic impedance cardiography: a noninvasive method of hemodynamic assessment.
    Bayram M; Yancy CW
    Heart Fail Clin; 2009 Apr; 5(2):161-8. PubMed ID: 19249685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors.
    Abraham WT
    Europace; 2013 Jun; 15 Suppl 1():i40-i46. PubMed ID: 23737229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using devices for physiologic monitoring in heart failure.
    Rathman L; Repoley J; Delgado S; Trupp R
    J Cardiovasc Nurs; 2008; 23(2):159-68. PubMed ID: 18382259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.